Related references
Note: Only part of the references are listed.Impact of commonly used drugs on the composition and metabolic function of the gut microbiota
Arnau Vich Vila et al.
NATURE COMMUNICATIONS (2020)
Statin therapy is associated with lower prevalence of gut microbiota dysbiosis
Sara Vieira-Silva et al.
NATURE (2020)
Host variables confound gut microbiota studies of human disease
Ivan Vujkovic-Cvijin et al.
NATURE (2020)
Extensive transmission of microbes along the gastrointestinal tract
Thomas S. B. Schmidt et al.
ELIFE (2019)
NG-meta-profiler: fast processing of metagenomes using NGLess, a domain-specific language
Luis Pedro Coelho et al.
MICROBIOME (2019)
Definition, Classification and Diagnosis of Diabetes Mellitus
Astrid Petersmann et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2019)
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Paul K. Whelton et al.
HYPERTENSION (2018)
Enterotypes in the landscape of gut microbial community composition
Paul I. Costea et al.
NATURE MICROBIOLOGY (2018)
The Human Gut Microbiome: From Association to Modulation
Thomas S. B. Schmidt et al.
CELL (2018)
Gut microbiota associations with common diseases and prescription medications in a population-based cohort
Matthew A. Jackson et al.
NATURE COMMUNICATIONS (2018)
Extensive impact of non-antibiotic drugs on human gut bacteria
Lisa Maier et al.
NATURE (2018)
Environment dominates over host genetics in shaping human gut microbiota
Daphna Rothschild et al.
NATURE (2018)
Recovery of gut microbiota of healthy adults following antibiotic exposure
Albert Palleja et al.
NATURE MICROBIOLOGY (2018)
Systematic review: human gut dysbiosis induced by non-antibiotic prescription medications
Q. Le Bastard et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
Clyde W. Yancy et al.
JOURNAL OF CARDIAC FAILURE (2017)
Quantitative microbiome profiling links gut community variation to microbial load
Doris Vandeputte et al.
NATURE (2017)
Assessment of variation in microbial community amplicon sequencing by the Microbiome Quality Control (MBQC) project consortium
Rashmi Sinha et al.
NATURE BIOTECHNOLOGY (2017)
Towards standards for human fecal sample processing in metagenomic studies
Paul I. Costea et al.
NATURE BIOTECHNOLOGY (2017)
Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug
Hao Wu et al.
NATURE MEDICINE (2017)
Dietary Assessment in the MetaCardis Study: Development and Relative Validity of an Online Food Frequency Questionnaire
Eric O. Verger et al.
JOURNAL OF THE ACADEMY OF NUTRITION AND DIETETICS (2017)
metaSNV: A tool for metagenomic strain level analysis
Paul Igor Costea et al.
PLOS ONE (2017)
The influence of proton pump inhibitors and other commonly used medication on the gut microbiota
Floris Imhann et al.
GUT MICROBES (2017)
Proton pump inhibitors affect the gut microbiome
Floris Imhann et al.
GUT (2016)
MOCAT2: a metagenomic assembly, annotation and profiling framework
Jens Roat Kultima et al.
BIOINFORMATICS (2016)
Anti-Inflammatory Effects of Metformin Irrespective of Diabetes Status
Amy R. Cameron et al.
CIRCULATION RESEARCH (2016)
Antibiotic use and its consequences for the normal microbiome
Martin J. Blaser
SCIENCE (2016)
Population-level analysis of gut microbiome variation
Gwen Falony et al.
SCIENCE (2016)
Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota
Kristoffer Forslund et al.
NATURE (2015)
Influence of Proton-Pump Inhibitors on the Luminal Microbiota in the Gastrointestinal Tract
Ayumi Tsuda et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2015)
The Impact of Diet and Lifestyle on Gut Microbiota and Human Health
Michael A. Conlon et al.
NUTRIENTS (2015)
γ-Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of L-Carnitine to TMAO
Robert A. Koeth et al.
CELL METABOLISM (2014)
An integrated catalog of reference genes in the human gut microbiome
Junhua Li et al.
NATURE BIOTECHNOLOGY (2014)
Identification and assembly of genomes and genetic elements in complex metagenomic samples without using reference genomes
H. Bjorn Nielsen et al.
NATURE BIOTECHNOLOGY (2014)
ALIENTRIMMER: A tool to quickly and accurately trim off multiple short contaminant sequences from high-throughput sequencing reads
Alexis Criscuolo et al.
GENOMICS (2013)
Richness of human gut microbiome correlates with metabolic markers
Emmanuelle Le Chatelier et al.
NATURE (2013)
Dietary intervention impact on gut microbial gene richness
Aurelie Cotillard et al.
NATURE (2013)
Metagenomic species profiling using universal phylogenetic marker genes
Shinichi Sunagawa et al.
NATURE METHODS (2013)
Suppression of Oxidative Stress by β-Hydroxybutyrate, an Endogenous Histone Deacetylase Inhibitor
Tadahiro Shimazu et al.
SCIENCE (2013)
Monitoring microbiological changes in drinking water systems using a fast and reproducible flow cytometric method
E. I. Prest et al.
WATER RESEARCH (2013)
The potential role of glutamate in the current diabetes epidemic
Alberto M. Davalli et al.
ACTA DIABETOLOGICA (2012)
Enterotypes of the human gut microbiome
Manimozhiyan Arumugam et al.
NATURE (2011)
A General Approach to Causal Mediation Analysis
Kosuke Imai et al.
PSYCHOLOGICAL METHODS (2010)
Increased plasma concentration of macrophage migration inhibitory factor (MIF) and MIF mRNA in mononuclear cells in the obese and the suppressive action of metformin
P Dandona et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Quantifying the risk of infectious diseases for people with diabetes
BR Shah et al.
DIABETES CARE (2003)